| Lastest Insider Transactions Of MADRIGAL PHARMACEUTICALS, INC. ( MDGL ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-12-03 | Sell | 2,400 | 575.34 | 1,380,816 | 2025-12-04 17:26:58 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-12-03 | Option Exercise | 50,000 | 0.00 | 0 | 2025-12-04 17:26:58 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | 2025-12-02 | Sell | 4,173 | 578.34 | 2,413,417 | 2025-12-03 17:59:33 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | 2025-12-02 | Option Exercise | 4,173 | 251.63 | 1,050,052 | 2025-12-03 17:59:33 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | 2025-12-02 | Sell | 4,173 | 578.34 | 2,413,417 | 2025-12-03 17:59:33 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | 2025-12-02 | Option Exercise | 4,173 | 251.63 | 1,050,052 | 2025-12-03 17:59:33 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | 2025-11-21 | Sell | 1,958 | 553.11 | 1,082,986 | 2025-11-21 17:39:36 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2025-11-13 | Sell | 8,500 | 520.96 | 4,428,198 | 2025-11-14 17:12:26 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2025-11-13 | Option Exercise | 8,500 | 13.78 | 117,160 | 2025-11-14 17:12:26 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-11-05 | Sell | 16,575 | 484.30 | 8,027,354 | 2025-11-07 16:20:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-11-05 | Option Exercise | 16,575 | 205.07 | 3,399,036 | 2025-11-07 16:20:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-09-09 | Sell | 7,279 | 445.63 | 3,243,741 | 2025-09-09 21:07:34 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-09-09 | Sell | 7,279 | 445.63 | 3,243,741 | 2025-09-09 21:07:34 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-08-21 | Sell | 7,616 | 400.18 | 3,047,756 | 2025-08-21 17:44:27 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2025-08-18 | Buy | 97,065 | 380.58 | 36,941,196 | 2025-08-20 18:12:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2025-08-18 | Buy | 68,618 | 364.04 | 24,979,828 | 2025-08-20 18:09:53 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | 2025-08-18 | Sell | 1,304 | 367.81 | 479,627 | 2025-08-18 17:33:51 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-08-15 | Sell | 10,000 | 365.20 | 3,652,009 | 2025-08-15 18:04:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-08-15 | Option Exercise | 10,000 | 16.46 | 164,600 | 2025-08-15 18:04:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-13 | Sell | 129,172 | 370.24 | 47,825,148 | 2025-08-13 18:18:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-13 | Option Exercise | 129,172 | 9.45 | 1,220,675 | 2025-08-13 18:18:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-13 | Sell | 129,172 | 370.24 | 47,825,148 | 2025-08-13 18:18:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-13 | Option Exercise | 129,172 | 9.45 | 1,220,675 | 2025-08-13 18:18:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-11 | Sell | 46,808 | 355.31 | 16,631,386 | 2025-08-13 17:45:49 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-08-11 | Option Exercise | 46,808 | 9.45 | 442,336 | 2025-08-13 17:45:49 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-08-11 | Sell | 46,463 | 355.32 | 16,509,032 | 2025-08-13 17:33:26 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-08-11 | Option Exercise | 46,463 | 9.45 | 439,075 | 2025-08-13 17:33:26 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-07-18 | Sell | 1,000 | 350.00 | 350,005 | 2025-07-22 17:08:54 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-07-18 | Option Exercise | 1,000 | 9.45 | 9,450 | 2025-07-22 17:08:54 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-07-18 | Sell | 1,400 | 350.03 | 490,044 | 2025-07-22 17:06:59 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-07-18 | Option Exercise | 1,400 | 9.45 | 13,230 | 2025-07-22 17:06:59 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-07-16 | Sell | 28,876 | 353.19 | 10,198,844 | 2025-07-18 16:13:03 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2025-07-16 | Option Exercise | 28,876 | 9.45 | 272,878 | 2025-07-18 16:13:03 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-07-16 | Sell | 29,101 | 353.19 | 10,278,098 | 2025-07-18 16:11:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Directior | 2025-07-16 | Option Exercise | 29,101 | 9.45 | 275,004 | 2025-07-18 16:11:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2025-03-12 | Sell | 15,470 | 328.54 | 5,082,480 | 2025-03-14 16:25:06 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2025-03-12 | Option Exercise | 15,470 | 82.90 | 1,282,478 | 2025-03-14 16:25:06 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | SVP and CFO | 2025-03-10 | Sell | 258 | 323.04 | 83,344 | 2025-03-12 16:32:09 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sell | 14,113 | 341.32 | 4,817,104 | 2025-03-07 17:40:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Option Exercise | 14,113 | 87.49 | 1,234,766 | 2025-03-07 17:40:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sell | 14,113 | 341.32 | 4,817,104 | 2025-03-07 17:40:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Option Exercise | 14,113 | 87.49 | 1,234,766 | 2025-03-07 17:40:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | 2025-03-03 | Sell | 415 | 335.00 | 139,025 | 2025-03-05 16:36:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | SVP and CFO | 2025-03-03 | Sell | 1,961 | 324.96 | 637,248 | 2025-03-05 16:31:51 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | 2025-03-03 | Sell | 1,834 | 325.98 | 597,840 | 2025-03-05 16:24:29 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-02-28 | Sell | 1,227 | 341.07 | 418,488 | 2025-03-04 21:24:28 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-02-27 | Option Exercise | 50,000 | 0.00 | 0 | 2025-02-28 16:36:27 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Directior | 2025-02-27 | Sell | 15,470 | 347.45 | 5,375,126 | 2025-02-28 16:31:10 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Directior | 2025-02-27 | Option Exercise | 15,470 | 82.90 | 1,282,478 | 2025-02-28 16:31:10 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-02-27 | Sell | 20,000 | 356.44 | 7,128,759 | 2025-02-28 16:30:17 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2025-02-27 | Option Exercise | 20,000 | 66.26 | 1,325,287 | 2025-02-28 16:30:17 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | 2025-01-24 | Sell | 347 | 335.24 | 116,328 | 2025-01-27 17:18:36 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2025-01-24 | Sell | 1,584 | 335.24 | 531,020 | 2025-01-27 17:12:21 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2025-01-24 | Sell | 648 | 335.24 | 217,236 | 2025-01-27 17:07:51 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-01-24 | Sell | 103 | 335.24 | 34,530 | 2025-01-27 17:03:07 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | 2025-01-17 | Sell | 277 | 273.41 | 75,735 | 2025-01-17 19:10:30 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-01-17 | Sell | 442 | 273.41 | 120,847 | 2025-01-17 19:08:21 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2025-01-17 | Sell | 1,689 | 273.41 | 461,790 | 2025-01-17 19:05:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2024-12-03 | Sell | 3,600 | 315.31 | 1,135,122 | 2024-12-05 16:46:45 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2024-11-25 | Sell | 3,400 | 350.30 | 1,191,028 | 2024-11-27 16:16:14 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-11-07 | Sell | 5,000 | 350.00 | 1,750,000 | 2024-11-08 17:07:14 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-11-07 | Option Exercise | 5,000 | 7.36 | 36,800 | 2024-11-08 17:07:14 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-11-01 | Sell | 5,000 | 300.94 | 1,504,703 | 2024-11-05 19:01:47 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-11-01 | Option Exercise | 5,000 | 7.36 | 36,800 | 2024-11-05 19:01:47 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO | 2024-09-09 | Sell | 6,363 | 243.83 | 1,551,490 | 2024-09-11 21:51:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2024-06-14 | Sell | 1,900 | 280.00 | 532,000 | 2024-06-18 21:39:28 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2024-06-14 | Option Exercise | 1,900 | 87.09 | 165,471 | 2024-06-18 21:39:28 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2024-06-12 | Sell | 2,000 | 285.00 | 570,000 | 2024-06-14 21:44:36 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2024-06-12 | Option Exercise | 2,000 | 87.92 | 175,840 | 2024-06-14 21:44:36 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2024-05-21 | Sell | 1,036 | 231.34 | 239,668 | 2024-05-23 21:36:56 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2024-05-14 | Sell | 22,489 | 212.88 | 4,787,404 | 2024-05-16 21:53:56 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | CRAVES FRED B | Directior | 2024-05-14 | Option Exercise | 22,489 | 103.02 | 2,316,844 | 2024-05-16 21:53:56 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2024-04-08 | Sell | 2,676 | 245.99 | 658,258 | 2024-04-10 20:53:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2024-04-08 | Option Exercise | 2,676 | 9.45 | 25,288 | 2024-04-10 20:53:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2024-04-08 | Sell | 26,270 | 246.19 | 6,467,491 | 2024-04-10 20:50:27 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2024-04-08 | Option Exercise | 26,270 | 9.45 | 248,252 | 2024-04-10 20:50:27 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sell | 73,888 | 243.92 | 18,022,588 | 2024-04-05 20:50:35 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Option Exercise | 73,888 | 9.45 | 698,242 | 2024-04-05 20:50:35 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2024-04-03 | Sell | 73,730 | 243.93 | 17,984,804 | 2024-04-05 20:50:16 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Directior | 2024-04-03 | Option Exercise | 73,730 | 9.45 | 696,749 | 2024-04-05 20:50:16 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-04-01 | Sell | 11,000 | 257.48 | 2,832,335 | 2024-04-03 20:47:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2024-04-01 | Option Exercise | 11,000 | 63.92 | 703,160 | 2024-04-03 20:47:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2024-04-01 | Sell | 32,489 | 252.85 | 8,214,998 | 2024-04-03 20:44:23 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Directior | 2024-04-01 | Option Exercise | 32,489 | 74.22 | 2,411,344 | 2024-04-03 20:44:23 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Directior | 2024-04-01 | Sell | 32,489 | 252.97 | 8,218,631 | 2024-04-03 20:41:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Directior | 2024-04-01 | Option Exercise | 32,489 | 102.23 | 3,321,344 | 2024-04-03 20:41:46 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-14 | Sell | 4,000 | 235.50 | 942,000 | 2023-12-18 16:30:24 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-14 | Option Exercise | 4,000 | 87.92 | 351,680 | 2023-12-18 16:30:24 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-12-13 | Buy | 101,792 | 221.20 | 22,516,576 | 2023-12-14 18:10:59 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-12-12 | Buy | 34,578 | 218.31 | 7,548,616 | 2023-12-14 18:09:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-12 | Sell | 3,800 | 222.82 | 846,700 | 2023-12-14 16:30:08 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-12 | Option Exercise | 3,800 | 87.92 | 334,096 | 2023-12-14 16:30:08 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-12-04 | Sell | 2,800 | 221.89 | 621,294 | 2023-12-06 16:30:08 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-12-04 | Option Exercise | 2,800 | 83.28 | 233,180 | 2023-12-06 16:30:08 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-11-29 | Sell | 7,000 | 201.50 | 1,410,480 | 2023-12-01 16:30:07 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-11-29 | Option Exercise | 7,000 | 73.75 | 516,250 | 2023-12-01 16:30:07 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-11-21 | Buy | 64,350 | 188.47 | 12,128,340 | 2023-11-21 18:15:19 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-11-17 | Buy | 67,079 | 178.11 | 11,947,280 | 2023-11-21 18:14:12 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-11-14 | Buy | 49,387 | 158.13 | 7,809,559 | 2023-11-15 17:13:57 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Directior | 2023-11-13 | Buy | 107,499 | 146.99 | 15,801,021 | 2023-11-15 17:12:53 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-02-28 | Sell | 10,000 | 273.24 | 2,732,438 | 2023-03-02 16:30:31 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-02-28 | Option Exercise | 10,000 | 87.92 | 879,200 | 2023-03-02 16:30:31 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2023-01-17 | Sell | 22,489 | 293.15 | 6,592,686 | 2023-01-19 19:57:34 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Directior | 2023-01-17 | Option Exercise | 22,489 | 103.02 | 2,316,844 | 2023-01-19 19:57:34 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-01-03 | Sell | 13,000 | 282.92 | 3,677,977 | 2023-01-06 09:08:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2023-01-03 | Option Exercise | 13,000 | 91.79 | 1,193,270 | 2023-01-06 09:08:05 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2022-12-23 | Sell | 7,000 | 274.18 | 1,919,231 | 2022-12-28 20:00:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP and General Counsel | 2022-12-23 | Option Exercise | 7,000 | 91.79 | 642,530 | 2022-12-28 20:00:22 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sukhija Remy | Chief Commercial Officer | 2022-12-23 | Sell | 30,000 | 274.14 | 8,224,074 | 2022-12-28 20:00:15 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sukhija Remy | Chief Commercial Officer | 2022-12-23 | Option Exercise | 30,000 | 60.26 | 1,807,800 | 2022-12-28 20:00:15 |
